|
|
References
|
|
|
*** (1997) Passa P diabetic nephropathy in the NIDDM patient on the interface between diabetology and nephrology: What do we have to improve?. Nephrol Dial Transplant, 12, str. 1316-1317
|
|
 
|
*** (1991) Prevention of peritonitis in CAPD. Lancet, 337(8732): 22-3
|
|
|
*** (2003) Organ procurements and transplantation network kidney Kaplan-Meier graft survival rates for transplants performed: 1996-2001. based on OPTN data as of March 28 http://www.optn.org/latestData/rptStrat.asp
|
|

|
Abbott, K.C., Hypolite, I.O., Hshieh, P., Cruess, D., Agodoa, L.Y., Welch, P.G., Taylor, A.J., Yuan, C.M. (2001) The impact of renal transplantation on the incidence of congestive heart failure in patients with end-stage renal disease due to diabetes. J Nephrol, 14(5): 369-76
|
|
 
|
Abdel-Rahman, E., Bolton, W. (2002) Pimagedine: A novel therapy for diabetic nephropathy. Expert Opin Investig Drugs, 11(4): 565-74
|
|

|
Abourizk, N.N., Dunn, J.C. (1990) Types of diabetes according to National Diabetes. Data Group Classification. Limited applicability and need to revisit. Diabetes Care, 13(11): 1120-3
|
|
 
|
Archibald, V., Cotter, M.A., Keegan, A., Cameron, N.E. (1996) Contraction and relaxation of aortas from diabetic rats: Effects of chronic anti-oxidant and aminoguanidine treatments. Naunyn Schmiedebergs Arch Pharmacol, 353(5): 584-91
|
|
|
Armenti, F.T., Radomski, J.S., Moritz, M.J., i dr. (2001) Report from the National Transplantation Pregnancy Registry (NPTR): Outcomes of pregnancy after transplantation. in: Cecka and Terasaki (ed.) Clinical Transplants, Los Angeles: UCLA - Immunogenetics Center, Pp 97-105
|
|

|
Ar'Rajab, A., Dawidson, I.J., Harris, R.B., Sentementes, J.T. (1994) Immune privilege of the testis for islet xenotransplantation (rat to mouse). Transplant Proc, 26(6): 3446
|
|
 1
|
Bank, N., Aynedjian, H.S. (1993) Role of EDRF (nitric oxide) in diabetic renal hyperfiltration. Kidney Int, 43(6): 1306-12
|
|

|
Battle, W.M., Cohen, J.D., Snape, W.J. (1983) Disorders of colonic motility in patients with diabetes mellitus. Yale J Biol Med, 56(4): 277-83
|
|

|
Berman, D.H., Friedman, E.A., Lundin, A.P. (1992) Aggressive ophthalmological management in diabetic end-stage renal disease: A study of 31 consecutively referred patients. Am J Nephrol, 12(5): 344-50
|
|

|
Biesenbach, G., Janko, O., Zazgornik, J. (1994) Similar rate of progression in the predialysis phase in type I and type II diabetes mellitus. Nephrol Dial Transplant, 9(8): 1097-102
|
|
 
|
Blohme, G., Nystrom, L., Arnqvist, H.J., Lithner, F., Littorin, B., Olsson, P.O., Schersten, B., Wibell, L., Ostman, J. (1992) Male predominance of type 1 (insulin-dependent) diabetes mellitus in young adults: Results from a 5-year prospective nationwide study of the 15-34-year age group in Sweden. Diabetologia, 35(1): 56-62
|
|
|
Braun, W.E., Phillips, D., Vidt, D.G., i dr. (1983) The course of coronary artery disease in diabetics with and without renal allografts. Transplant Proc, 15, str. 1114-1119
|
|
 
|
Brownlee, M., Vlassara, H., Kooney, A., Ulrich, P. (1986) Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science, 232(4758): 1629-32
|
|
  5
|
Brownlee, M., Cerami, A., Vlassara, H. (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med, 318(20): 1315-21
|
|

|
Brownlee, M. (1989) Pharmacological modulation of the advanced glycosylation reaction. Prog Clin Biol Res, 304: 235-48
|
|

|
Brunner, F.P., Fassbinder, W., Broyer, M., Oules, R., Brynger, H., Rizzoni, G., Challah, S., Selwood, N.H., Dykes, S.R., Wing, A.J. (1988) Survival on renal replacement therapy: Data from the EDTA Registry. Nephrol Dial Transplant, 3(2): 109-22
|
|
  1
|
Bucala, R., Tracey, K.J., Cerami, A. (1991) Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest, 87(2): 432-8
|
|
 
|
Burton, P.R., Walls, J. (1987) Selection-adjusted comparison of life-expectancy of patients on continuous ambulatory peritoneal dialysis, haemodialysis, and renal transplantation. Lancet, 1(8542): 1115-9
|
|

|
Carlson, D.M., Johnson, W.J., Kjellstrand, C.M. (1987) Functional status of patients with end-stage renal disease. Mayo Clin Proc, 62(5): 338-44
|
|
|
Centers for Disease Control and Prevention (2002) Diabetes: Disabling, deadly, and on the rise National Diabetes Fact Sheet: National estimates and general information on diabetes in the United States. Atlanta, GA: National Center for Chronic Disease Prevention and Health Promotion
|
|
|
Cheigh, J., Raghavan, J., Sullivan, J., Tapia, L., Rubin, A., Stenzel, K.H. (1991) Is insufficient dialysis a cause for high morbidity in diabetic patients?. J Am Soc Nephrol, 317 (abstract)
|
|

|
Clark, D.W., Nowak, T.V. (1994) Diabetic gastroparesis. What to do when gastric emptying is delayed. Postgrad Med, 95(5): 195-8, 201
|
|
 
|
Corbett, J.A., Tilton, R.G., Chang, K., Hasan, K.S., Ido, Y., Wang, J.L., Sweetland, M.A., Lancaster, J.R., Williamson, J.R., McDaniel, M.L. (1992) Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes, 41(4): 552-6
|
|
 
|
Cosio, F.G., Pesavento, T.E., Osei, K., Henry, M.L., Ferguson, R.M. (2001) Post-transplant diabetes mellitus: Increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int, 59(2): 732-7
|
|
 
|
Council on Ethical and Judicial Affairs (1990) Black-white disparities in health care. JAMA, 263(17): 2344-6
|
|

|
Duijnhoven, E.M., Boots, J.M., Christiaans, M.H., Wolffenbuttel, B.H., van Hooff, J.P. (2001) Influence of tacrolimus on glucose metabolism before and after renal transplantation: A prospective study. J Am Soc Nephrol, 12(3): 583-8
|
|
 
|
Edelstein, D., Brownlee, M. (1992) Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes, 41(1): 26-9
|
|
 
|
Ellis, E.N., Good, B.H. (1991) Prevention of glomerular basement membrane thickening by aminoguanidine in experimental diabetes mellitus. Metabolism, 40(10): 1016-9
|
|
 
|
Filler, G., Neuschulz, I., Vollmer, I., Amendt, P., Hocher, B. (2000) Tacrolimus reversibly reduces insulin secretion in paediatric renal transplant recipients. Nephrol Dial Transplant, 15(6): 867-71
|
|
|
Fioretto, P., Steffes, M.W., Sutherland, D.E.R., Goetz, F.C., Mauer, M. (1997) Successful pancreas transplantation alone reverses established lesions of diabetic nephropathy in man. J Am Soc Nephrol, 8: 111A
|
|
  1
|
Fioretto, P., Steffes, M.W., Sutherland, D.E., Goetz, F.C., Mauer, M. (1998) Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med, 339(2): 69-75
|
|
 
|
First, M.R., Gerber, D.A., Hariharan, S., Kaufman, D.B., Shapiro, R. (2002) Posttransplant diabetes mellitus in kidney allograft recipients: Incidence, risk factors, and management. Transplantation, 73(3): 379-86
|
|
 
|
Forbes, J.M., Soulis, T., Thallas, V., Panagiotopoulos, S., Long, D.M., Vasan, S., Wagle, D., Jerums, G., Cooper, M.E. (2001) Renoprotective effects of a novel inhibitor of advanced glycation. Diabetologia, 44(1): 108-14
|
|
 
|
Freedman, B.I., Wuerth, J.P., Cartwright, K., Bain, R.P., Dippe, S., Hershon, K., Mooradian, A.D., Spinowitz, B.S. (1999) Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II). Control Clin Trials, 20(5): 493-510
|
|

|
Friedman, E.A., Shyh, T.P., Beyer, M.M., Manis, T., Butt, K.M. (1985) Posttransplant diabetes in kidney transplant recipients. Am J Nephrol, 5(3): 196-202
|
|
|
Friedman, E.A. (1994) Death on hemodialysis: Preventable or inevitable?. Dordrecht, itd: Kluwer Academic Publisher
|
|

|
Fryer, J.P., Granger, D.K., Leventhal, J.R., Gillingham, K., Najarian, J.S., Matas, A.J. (1994) Steroid-related complications in the cyclosporine era. Clin Transplant, 8(3 Pt 1): 224-9
|
|
 
|
Gokal, R., Jakubowski, C., King, J., Hunt, L., Bogle, S., Baillod, R., Marsh, F., Ogg, C., Oliver, D., Ward, M. (1987) Outcome in patients on continuous ambulatory peritoneal dialysis and haemodialysis: 4-year analysis of a prospective multicentre study. Lancet, 2(8568): 1105-9
|
|

|
Gray, D.W. (1990) Islet isolation and transplantation techniques in the primate. Surg Gynecol Obstet, 170(3): 225-32
|
|

|
Gruessner, A.C., Sutherland, D.E. (2001) Analysis of United States (US) and non-US pancreas transplants reported to the United network for organ sharing (UNOS) and the international pancreas transplant registry (IPTR) as of October 2001. Clin Transpl, : 41-72
|
|

|
Gutman, R.A., Stead, W.W., Robinson, R.R. (1981) Physical activity and employment status of patients on maintenance dialysis. N Engl J Med, 304(6): 309-13
|
|
 
|
Haffner, S.M., Hazuda, H.P., Stern, M.P., Patterson, J.K., van Heuven, W.A., Fong, D. (1989) Effects of socioeconomic status on hyperglycemia and retinopathy levels in Mexican Americans with NIDDM. Diabetes Care, 12(2): 128-34
|
|
 
|
Hammes, H.P., Brownlee, M., Edelstein, D., Saleck, M., Martin, S., Federlin, K. (1994) Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat. Diabetologia, 37(1): 32-5
|
|
 
|
Harris, M.I., Eastman, R.C. (1996) Early detection of undiagnosed non-insulin-dependent diabetes mellitus. JAMA, 276(15): 1261-2
|
|
 
|
Harris, M.I., Hadden, W.C., Knowler, W.C., Bennett, P.H. (1987) Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes, 36(4): 523-34
|
|

|
Hathaway, D.K., Tolley, E.A., Blakely, M.L., Winsett, R.P., Gaber, A.O. (1993) Development of an index to predict posttransplant diabetes mellitus. Clin Transplant, 7(4): 330-8
|
|
 
|
Hjelmesaeth, J., Hartmann, A., Kofstad, J., Stenstrom, J., Leivestad, T., Egeland, T., Fauchald, P. (1997) Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation, 64(7): 979-83
|
|
 
|
Hypolite, I.O., Bucci, J., Hshieh, P., Cruess, D., Agodoa, L.Y.C., Yuan, C.M., Taylor, A.J., Abbott, K.C. (2002) Acute coronary syndromes after renal transplantation in patients with end-stage renal disease resulting from diabetes. Am J Transplant, 2(3): 274-81
|
|

|
Ifudu, O., Paul, H., Mayers, J.D., Cohen, L.S., Brezsnyak, W.F., Herman, A.I., Avram, M.M., Friedman, E.A. (1994) Pervasive failed rehabilitation in center-based maintenance hemodialysis patients. Am J Kidney Dis, 23(3): 394-400
|
|
 
|
Ifudu, O., Mayers, J., Matthew, J., Tan, C.C., Cambridge, A., Friedman, E.A. (1994) Dismal rehabilitation in geriatric inner-city hemodialysis patients. JAMA, 271(1): 29-33
|
|
2
|
Karnofsky, D.A., Burchenal, J.H. (1949) The clinical evaluation of chemotherapeutic agents in cancer. in: Macleod C.M. (ed.) Evaluation of Chemotherapeutic Agents, New York, itd: Columbia University Press, str. 191-205
|
|
 
|
Kasiske, B.L., Snyder, J.J., Gilbertson, D., Matas, A.J. (2003) Diabetes mellitus after kidney transplantation in the United States. Am J Transplant, 3(2): 178-85
|
|
 
|
Keshaviah, P., Collins, A.J., Ma, J.Z., Churchill, D.N., Thorpe, K.E. (2002) Survival comparison between hemodialysis and peritoneal dialysis based on matched doses of delivered therapy. J Am Soc Nephrol, 13 Suppl 1: S48-52
|
|
 
|
Khauli, R.B., Steinmuller, D.R., Novick, A.C., Buszta, C., Goormastic, M., Nakamoto, S., Vidt, D.G., Magnusson, M., Paganini, E., Schreiber, M.J. (1986) A critical look at survival of diabetics with end-stage renal disease. Transplantation versus dialysis therapy. Transplantation, 41(5): 598-602
|
|
|
Kjellstrand, C.M. (1992) Practical aspects of stopping dialysis and cultural differences. in: Kjellstrand Carl M., John B. Dossetor (ed.) Ethical Problems in Dialysis and Transplantation, Dordrecht, itd: Kluwer Academic Publisher
|
|

|
Koznarova, R., Saudek, F., Sosna, T., Adamec, M., Jedinakova, T., Boucek, P., Bartos, V., Lanska, V. (2000) Beneficial effect of pancreas and kidney transplantation on advanced diabetic retinopathy. Cell Transplant, 9(6): 903-8
|
|
 
|
Lebel, M., Kingma, I., Grose, J.H., Langlois, S. (1995) Effect of recombinant human erythropoietin therapy on ambulatory blood pressure in normotensive and in untreated borderline hypertensive hemodialysis patients. Am J Hypertens, 8(6): 545-51
|
|

|
Legrain, M., Rottembourg, J., Bentchikou, A., Poignet, J.L., Issad, B., Barthelemy, A., Strippoli, P., Gahl, G.M., de Groc, F. (1984) Dialysis treatment of insulin dependent diabetic patients: Ten years experience. Clin Nephrol, 21(1): 72-81
|
|

|
Leow, C.K., Shimizu, S., Gray, D.W., Morris, P.J. (1994) Successful pancreatic islet autotransplantation to the renal subcapsule in the cynomolgus monkey. Transplantation, 57(1): 161-4
|
|

|
Lindblad, A.S., Nolph, K.D., Novak, J.W., Friedman, E.A. (1988) A survey of the NIH CAPD Registry population with end-stage renal disease attributed to diabetic nephropathy. J Diabet Complications, 2(4): 227-32
|
|
  1
|
Lindholm, A., Albrechtsen, D., Frodin, L., Tufveson, G., Persson, N.H., Lundgren, G. (1995) Ischemic heart disease: Major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation, 60(5): 451-7
|
|

|
Lowder, G.M., Perri, N.A., Friedman, E.A. (1988) Demographics, diabetes type, and degree of rehabilitation in diabetic patients on maintenance hemodialysis in Brooklyn. J Diabet Complications, 2(4): 218-26
|
|

|
Lux, G. (1989) Disorders of gastrointestinal motility: Diabetes mellitus. Leber Magen Darm, 19(2): 84-93
|
|

|
Lyons, T.J., Bailie, K.E., Dyer, D.G., Dunn, J.A., Baynes, J.W. (1991) Decrease in skin collagen glycation with improved glycemic control in patients with insulin-dependent diabetes mellitus. J Clin Invest, 87(6): 1910-5
|
|
 
|
Maes, B.D., Kuypers, D., Messiaen, T., Evenepoel, P., Mathieu, C., Coosemans, W., Pirenne, J., Vanrenterghem, Y.F. (2001) Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: Analysis of incidence and risk factors. Transplantation, 72(10): 1655-61
|
|

|
Maiorca, R., Cancarini, G., Manili, L., Brunori, G., Camerini, C., Strada, A., Feller, P. (1988) CAPD is a first class treatment: Results of an eight-year experience with a comparison of patient and method survival in CAPD and hemodialysis. Clin Nephrol, 30 Suppl 1: S3-7
|
|
 1
|
Makita, Z., Radoff, S., Rayfield, E.J., Yang, Z., Skolnik, E., Delaney, V., Friedman, E.A., Cerami, A., Vlassara, H. (1991) Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med, 325(12): 836-42
|
|
 
|
Marshak, S., Leibowitz, G., Bertuzzi, F., Socci, C., Kaiser, N., Gross, D.J., Cerasi, E., Melloul, D. (1999) Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose. Diabetes, 48(6): 1230-6
|
|

|
Mauer, S.M., Chavers, B.M. (1985) A comparison of kidney disease in type I and type II diabetes. Adv Exp Med Biol, 189: 299-303
|
|
2
|
Meisel, A. (1989) The right to die. New York, itd: Wiley
|
|
 
|
Melton, L.J., Palumbo, P.J., Chu, C.P. (1983) Incidence of diabetes mellitus by clinical type. Diabetes Care, 6(1): 75-86
|
|
 
|
Miguel, A., Garcia-Ramon, R., Perez-Contreras, J., Gomez-Roldan, C., Alvarino, J., Escobedo, J., Garcia, H., Lanuza, M., Lopez-Menchero, R., Olivares, J., Tornero, F., Albero, D., Levante PD Multicenter group (2002) Comorbidity and mortality in peritoneal dialysis: A comparative study of type 1 and 2 diabetes versus nondiabetic patients. Peritoneal dialysis and diabetes. Nephron, 90(3): 290-6
|
|
 
|
Miles, A.M., Sumrani, N., Horowitz, R., Homel, P., Maursky, V., Markell, M.S., Distant, D.A., Hong, J.H., Sommer, B.G., Friedman, E.A. (1998) Diabetes mellitus after renal transplantation: As deleterious as non-transplant-associated diabetes?. Transplantation, 65(3): 380-4
|
|

|
Miyauchi, Y., Shikama, H., Takasu, T., Okamiya, H., Umeda, M., Hirasaki, E., Ohhata, I., Nakayama, H., Nakagawa, S. (1996) Slowing of peripheral motor nerve conduction was ameliorated by aminoguanidine in streptozocin-induced diabetic rats. Eur J Endocrinol, 134(4): 467-73
|
|
 12
|
Moncada, S., Palmer, R.M., Higgs, E.A. (1991) Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev, 43(2): 109-42
|
|
 
|
Najarian, J.S., Sutherland, D.E., Simmons, R.L., Howard, R.J., Kjellstrand, C.M., Ramsay, R.C., Goetz, F.C., Fryd, D.S., Sommer, B.G. (1979) Ten year experience with renal transplantation in juvenile onset diabetics. Ann Surg, 190(4): 487-500
|
|
|
National Center for Health Statistics (1999) Health: United States 1998. Hyattsville Maryland: Public Health Service
|
|
|
National Diabetes Data Group (1985) Diabetes in America. NIH Publication, br. 85-1468, Aug
|
|

|
Nicholls, K., Mandel, T.E. (1989) Advanced glycosylation end-products in experimental murine diabetic nephropathy: Effect of islet isografting and of aminoguanidine. Lab Invest, 60(4): 486-91
|
|

|
Norton, G.R., Candy, G., Woodiwiss, A.J. (1996) Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocin-induced diabetes mellitus in rats. Circulation, 93(10): 1905-12
|
|
|
Odorico, J.S., Becker, Y.T., van der Werf, W., Collins, B., d'Alessandro A.M., Knechtle, S.J., Pirsch, J.D., Sollinger, H.W. (1997) Advances in pancreas transplantation: The University of Wisconsin experience. in: Cecka and Terasaki (ed.) Clinical Transplants, Los Angeles, CA: UCLA Tissue Typing Laboratory
|
|
 
|
Ojo, A.O., Hanson, J.A., Wolfe, R.A., Leichtman, A.B., Agodoa, L.Y., Port, F.K. (2000) Long-term survival in renal transplant recipients with graft function. Kidney Int, 57(1): 307-13
|
|

|
Papanastasiou, P., Grass, L., Rodela, H., Patrikarea, A., Oreopoulos, D., Diamandis, E.P. (1994) Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPD. Kidney Int, 46(1): 216-22
|
|
 
|
Philipson, J.D., Carpenter, B.J., Itzkoff, J., Hakala, T.R., Rosenthal, J.T., Taylor, R.J., Puschett, J.B. (1986) Evaluation of cardiovascular risk for renal transplantation in diabetic patients. Am J Med, 81(4): 630-4
|
|
 
|
Polonsky, K.S. (1995) Lilly Lecture 1994. The beta-cell in diabetes: From molecular genetics to clinical research. Diabetes, 44(6): 705-17
|
|
 
|
Pommer, W., Bressel, F., Chen, F., Molzahn, M. (1997) There is room for improvement of preterminal care in diabetic patients with end-stage renal failure: The epidemiological evidence in Germany. Nephrol Dial Transplant, 12(7): 1318-20
|
|
 
|
Rabkin, J.M., Leone, J.P., Sutherland, D.E., Ahman, A., Reed, M., Papalois, B.E., Wahoff, D.C. (1997) Transcontinental shipping of pancreatic islets for autotransplantation after total pancreatectomy. Pancreas, 15(4): 416-9
|
|
 
|
Rahbar, S., Natarajan, R., Yerneni, K., Scott, S., Gonzales, N., Nadler, J.L. (2000) Evidence that pioglitazone, metformin and pentoxifylline are inhibitors of glycation. Clin Chim Acta, 301(1-2): 65-77
|
|
|
Rajagopalan, P.R., Rogers, J., Chavin, C., i dr. (2001) Cadaveric renal translantation in African-Americans in South Carolina. in: Cecka and Terasaki (ed.) Clinical Transplants, Los Angeles: UCLA - Immunogenetics Center, str. 143-147
|
|

|
Ramsay, R.C., Goetz, F.C., Sutherland, D.E., Mauer, S.M., Robison, L.L., Cantrill, H.L., Knobloch, W.H., Najarian, J.S. (1988) Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus. N Engl J Med, 318(4): 208-14
|
|
 1
|
Ritz, E., Stefanski, A. (1996) Diabetic nephropathy in type II diabetes. Am J Kidney Dis, 27(2): 167-94
|
|

|
Robertson, G.S., Dennison, A.R., Johnson, P.R., London, N.J. (1998) A review of pancreatic islet autotransplantation. Hepatogastroenterology, 45(19): 226-35
|
|
 
|
Rossing, P., Hougaard, P., Parving, H. (2002) Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: A 10-year prospective observational study. Diabetes Care, 25(5): 859-64
|
|
 
|
Roth, D., Milgrom, M., Esquenazi, V., Fuller, L., Burke, G., Miller, J. (1989) Posttransplant hyperglycemia. Increased incidence in cyclosporine-treated renal allograft recipients. Transplantation, 47(2): 278-81
|
|

|
Rubin, J., Hsu, H. (1991) Continuous ambulatory peritoneal dialysis: Ten years at one facility. Am J Kidney Dis, 17(2): 165-9
|
|
  1
|
Ryan, E.A., Lakey, J.R.T., Paty, B.W., Imes, S., Korbutt, G.S., Kneteman, N.M., Bigam, D., Rajotte, R.V., Shapiro, A. (2002) Successful islet transplantation: Continued insulin reserve provides long-term glycemic control. Diabetes, 51(7): 2148-57
|
|

|
Sabbatini, M., Sansone, G., Uccello, F., Giliberti, A., Conte, G., Andreucci, V.E. (1992) Early glycosylation products induce glomerular hyperfiltration in normal rats. Kidney Int, 42(4): 875-81
|
|
 
|
Sasaki, T.M., Gray, R.S., Ratner, R.E., Currier, C., Aquino, A., Barhyte, D.Y., Light, J.A. (1998) Successful long-term kidney-pancreas transplants in diabetic patients with high C-peptide levels. Transplantation, 65(11): 1510-2
|
|
   2
|
Schmidt, A.M., Hori, O., Chen, J.X., Li, J.F., Crandall, J., Zhang, J., Cao, R., Yan, S.D., Brett, J., Stern, D. (1995) Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diab. J Clin Invest, 96(3): 1395-403
|
|
 
|
Schmidt, R.E., Dorsey, D.A., Beaudet, L.N., Reiser, K.M., Williamson, J.R., Tilton, R.G. (1996) Effect of aminoguanidine on the frequency of neuroaxonal dystrophy in the superior mesenteric sympathetic autonomic ganglia of rats with streptozocin-induced diabetes. Diabetes, 45(3): 284-90
|
|
 
|
Schneider, D.J., Nordt, T.K., Sobel, B.E. (1993) Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patients. Diabetes, 42(1): 1-7
|
|

|
Sell, D.R., Monnier, V.M. (1990) End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen. J Clin Invest, 85(2): 380-4
|
|
 
|
Sheehy, M.J. (1992) HLA and insulin-dependent diabetes. A protective perspective. Diabetes, 41(2): 123-9
|
|
 
|
Silva, F., Queiros, J., Vargas, G., Henriques, A., Sarmento, A., Guimaraes, S. (2000) Risk factors for posttransplant diabetes mellitus and impact of this complication after renal transplantation. Transplant Proc, 32(8): 2609-10
|
|

|
Sims, E.A., Calles-Escandon, J. (1990) Classification of diabetes. A fresh look for the 1990s?. Diabetes Care, 13(11): 1123-8
|
|
 
|
Soulis-Liparota, T., Cooper, M.E., Dunlop, M., Jerums, G. (1995) The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley rat. Diabetologia, 38(4): 387-94
|
|

|
Stephens, G.W., Gillaspy, J.A., Clyne, D., Mejia, A., Pollak, V.E. (1990) Racial differences in the incidence of end-stage renal disease in types I and II diabetes mellitus. Am J Kidney Dis, 15(6): 562-7
|
|

|
Stevens, R.B., Lokeh, A., Ansite, J.D., Field, M.J., Gores, P.F., Sutherland, D.E. (1994) Role of nitric oxide in the pathogenesis of early pancreatic islet dysfunction during rat and human intraportal islet transplantation. Transplant Proc, 26(2): 692
|
|
 
|
Sumrani, N.B., Delaney, V., Ding, Z.K., Davis, R., Daskalakis, P., Friedman, E.A., Butt, K.M., Hong, J.H. (1991) Diabetes mellitus after renal transplantation in the cyclosporine era: An analysis of risk factors. Transplantation, 51(2): 343-7
|
|
 
|
Sutherland, D.E., Gores, P.F., Farney, A.C., Wahoff, D.C., Matas, A.J., Dunn, D.L., Gruessner, R.W., Najarian, J.S. (1993) Evolution of kidney, pancreas, and islet transplantation for patients with diabetes at the University of Minnesota. Am J Surg, 166(5): 456-91
|
|
 
|
Swamy-Mruthinti, S., Green, K., Abraham, E.C. (1996) Inhibition of cataracts in moderately diabetic rats by aminoguanidine. Exp Eye Res, 62(5): 505-10
|
|
 
|
Tuch, B.E., Wright, D.C., Martin, T.E., Keogh, G.W., Deol, H.S., Simpson, A.M., Roach, W., Pinto, A.N. (1999) Fetal pig endocrine cells develop when allografted into the thymus gland. Transplant Proc, 31(1-2): 670
|
|
1
|
US Renal Data System (2002) USRDS Annual Data Report atlas of end-stage disease in the United States. Bethesda, MD: National Institutes of Health / NIH - National Institute of Diabetes and Digestive and Kidney Diseases
|
|

|
Vlassara, H. (1994) Serum advanced glycosylation end products: A new class of uremic toxins?. Blood Purif, 12(1): 54-9
|
|
  2
|
Vlassara, H., Bucala, R., Striker, L. (1994) Pathogenic effects of advanced glycosylation: Biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest, 70(2): 138-51
|
|

|
Wahoff, D.C., Stephanian, E., Gores, P.F., Soon-Shiong, P., Hower, C., Lloveras, J.K., Sutherland, D.E. (1994) Intraperitoneal transplantation of microencapsulated canine islet allografts with short-term, low-dose cyclosporine for treatment of pancreatectomy-induced diabetes in dogs. Transplant Proc, 26(2): 804
|
|
 
|
Wahren, J., Johansson, B.L., Wallberg-Henriksson, H., Linde, B., Fernqvist-Forbes, E., Zierath, J.R. (1996) C-peptide revisited: New physiological effects and therapeutic implications. J Intern Med, 240(3): 115-24
|
|

|
Weir, M.R., Fink, J.C. (1999) Risk for posttransplant Diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis, 34(1): 1-13
|
|
 
|
White, C.A., Pilkey, R.M., Lam, M., Holland, D.C. (2002) Pre-dialysis clinic attendance improves quality of life among hemodialysis patients. BMC Nephrol, 3: 3
|
|
|
Whittier, F., Spinowitz, B., Wuerth, J.P., Cartwright, K. (1999) Pimagidine PG safety profile in patients with Type I diabetes mellitus DM. H Am Soc Nephrol, 10:184A (abstract)
|
|
 
|
Wilczek, H.E., Jaremko, G., Tyden, G., Groth, C.G. (1995) Evolution of diabetic nephropathy in kidney grafts: Evidence that a simultaneously transplanted pancreas exerts a protective effect. Transplantation, 59(1): 51-7
|
|

|
Wirta, O., Pasternack, A., Laippala, P., Turjanmaa, V. (1996) Glomerular filtration rate and kidney size after six years disease duration in non-insulin-dependent diabetic subjects. Clin Nephrol, 45(1): 10-7
|
|
 2
|
Zimmet, P.Z. (1992) Kelly West Lecture 1991. Challenges in diabetes epidemiology: From West to the rest. Diabetes Care, 15(2): 232-52
|
|
|
|
|